Management of drug eluting stent in‐stent restenosis: A systematic review and meta‐analysis
Catheterization and Cardiovascular Interventions2015Vol. 87(6), pp. 1080–1091
Citations Over TimeTop 10% of 2015 papers
Sachin S. Goel, Rama Dilip Gajulapalli, Ganesh Athappan, Femi Philip, Supriya Gupta, E. Murat Tuzcu, Stephen G. Ellis, Gregory Mishkel, Samir Kapadia
Abstract
Treatment of coronary DES ISR with DES or DEB is associated with a reduction in the risk of TLR and TVR compared to BA alone. The relative risk reduction for TLR with DES is similar to DEB. DEBs have a potential role in the treatment of DES ISR by avoiding placement of another layer of stent. © 2015 Wiley Periodicals, Inc.
Related Papers
- → Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent(2007)86 cited
- Delayed occurrence of restenosis in drug eluting stents: an evidence of delayed healing.(2005)
- An investigation into the influence of stent strut thickness on in-stent restenosis using the finite element method(2005)
- Prevention of In-stent Restenosis New Strategy(2013)
- PE-414 Preprocedual Inflammation State is Associated with Tissue Composition of In-Stent Restenosis(Restenosis after Angioplasty, Basic/Clinical 5 (IHD) : PE70)(Poster Session (English))(2004)